Metabolic syndrome with mortality and major adverse cardiovascular events in an elderly population

Shailendra Kumar Karn1, Fang Zhao2, Yawei Xu1

  • 1Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

PubMed

Insights

Metabolic syndrome (MS) independently predicts major adverse cardiovascular events (MACE) in older adults. Central obesity, hypertension, and hyperglycemia are key risk factors, highlighting the need for early MS management in the elderly.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a leading global health concern.
  • Metabolic syndrome (MS) significantly contributes to major adverse cardiovascular events (MACE).
  • Limited research exists on MS and long-term cardiovascular outcomes in elderly populations.

Purpose of the Study:

  • To investigate the impact of MS on MACE in an elderly cohort.
  • To identify specific MS components that predict MACE in older individuals.

Main Methods:

  • Prospective cohort study of 3,352 elderly residents (Northern Shanghai Study).
  • Average follow-up of 5.6 years.
  • MS defined by modified NCEP ATP III criteria; MACE included non-fatal MI, stroke, cardiovascular death, and all-cause mortality. Kaplan-Meier and logistic regression analyses were employed.

Main Results:

  • MS prevalence was 44.2% in the cohort.
  • Higher MACE incidence in participants with MS (12.69%) versus without (9.30%), p=0.02.
  • MS is an independent risk factor for MACE (HR 1.471, p=0.001); central obesity, hypertension, and hyperglycemia combination showed strongest prediction (HR 3.001, p<0.001).

Conclusions:

  • Metabolic syndrome is an independent predictor of MACE in the elderly.
  • Central obesity, hypertension, and hyperglycemia are critical risk factors within MS for MACE.
  • Early identification and management of MS are crucial for reducing cardiovascular risk and improving outcomes in older adults.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
776
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
3
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
26